跳至主要内容
临床试验/DRKS00023584
DRKS00023584已完成不适用

What can we learn from the implementation of a novel point-of-care Antigen-Based SARS-CoV-2 Rapid Diagnostic Test to Screen Incoming Patients in a large University Hospital? (COVID-19) - ANCOR

niversitätsklinikum Heidelberg0 个研究点目标入组 30 人开始时间: 2020年11月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 18 years or older; capable to give informed consent, having signed informed consent.
  • For heads of departments: Head of a department at UKHD currently employing a RDT-based COVID-19 testing strategy following the task-forces recommendation.
  • For practitioners: Medical practitioner (e.g. nurses, medical doctors) responsible for performing RDTs with patients at a clinic within UKHD.
  • For Patients: Patient admitted for elective care, emergency care, or outpatient treatment to a clinic within UKHD and having been tested for COVID-19 using a RDT.
  • Heads of non/late-implementing department: Head of a department at UKHD currently not employing a RDT-based COVID-19 testing strategy following the task-forces recommendation.
  • Task-Force Members: Member of the COVID-19 task force at UKHD involved in preparing the recommendation with regards to COVID-19 RDTs
  • Trainers: Individual responsible for capacity building for and implementation of RDT testing strategies at UKHD.

排除标准

  • Refusing or withdrawing informed consent; Incapacitated persons (mentally challenged; physical disability – i.e. hearing and speech impaired; totally blind)

研究者

发起方
niversitätsklinikum Heidelberg

相似试验